feed,title,long_url,short_url
Benzinga,SELLAS Life Sciences' GPS Combo Therapy Shows Overall Survival Of 18 Months In Pretreated Ovarian Cancer Patients,https://benzinga.com/general/biotech/22/11/29661241/sellas-life-sciences-gps-combo-therapy-shows-overall-survival-of-18-months-in-pretreated-ovarian-,https://bit.ly/3fXrNlS
